abrdn World Healthcare Fund Q1 2025 Commentary
Source: SeekingAlpha
2025-06-03 08:20:00 ET
Summary
- The equity portion of the Fund rose (gross of fees) but underperformed its benchmark over the quarter.
- The top three detractors over the quarter were Novo Nordisk, uniQure and Teva Pharmaceutical Industries.
- The top three positive contributors were Roche Holding, AbbVie and AstraZeneca.
Fund performance
Read the full article on Seeking Alpha
For further details see:
abrdn World Healthcare Fund Q1 2025 Commentary
Aberdeen Total Dynamic Dividend Fund
NASDAQ: AOD
AOD Trading
-1.81% G/L:
$9.53 Last:
432,206 Volume:
$9.63 Open:
AOD Latest News
March 10, 2026 04:17:00 pm
Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
January 12, 2026 04:17:00 pm
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
June 10, 2025 04:17:00 pm
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS
